Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metis MedTech is a Chicago-based investment and strategic advisory platform focused on medical device companies. The firm was launched in May 2026 by John Slump, former co-founder and CEO of Atraverse Medical, to support medtech founders with financing, regulatory strategy, commercialization, and company-building support. Rather than operating a traditional therapeutic pipeline, Metis MedTech appears to function as a founder-focused platform that provides capital and hands-on operating expertise to early-stage and growth-stage medical device companies. Publicly referenced investment and advisory activity includes work with Field Medical, Madison Scientific, and StimCardio Medical. The company is healthcare-related, but it is not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metis MedTech.